Photo of Yakup Ergün from obdh.com.tr
May 26, 2024, 13:42
Some of the highlights while waiting for ASCO24 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:
“Some of the highlights while waiting for ASCO24
Ab 1005
Enfortumab vedotin in TNBC and HR+/HER2– breast cancer (BC) cohorts of EV-202.
64% of patients with TNBC received ≥2L systemic tx, 73% of HR+ patients received ≥3L
ORR TNBC – %19
HR+ – 15.6%”
View the article attached to the post.
Source: Yakup Ergün/X
